ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Health In Tech (NASDAQ: HIT) Posts Blowout Q2, Stock Responds – HIT, SNYR, PNPN.V/PNPNF in Breakout Zone; See More to Watch Inside

NASDAQ: HIT) Posts Blowout Q2, Stock Responds - HIT, SNYR, PNPN.V/PNPNF in Breakout Zone; See More to Watch Inside" src="https://www.abnewswire.com/upload/2025/07/1753205205.jpg" alt="Health In Tech (NASDAQ: HIT) Posts Blowout Q2, Stock Responds - HIT, SNYR, PNPN.V/PNPNF in Breakout Zone; See More to Watch Inside" width="225" height="225">

Health In Tech (NASDAQ: HIT), a fast-growing Insurtech platform powered by third-party AI technology, announced second quarter financial results that underscored explosive growth and strong fundamentals, positioning the company as a standout in the digital health insurance sector.

Total revenue for Q2 2025 reached $9.3 million, an 86% increase year-over-year, while first-half revenues came in at $17.3 million — already 89% of the company’s full-year 2024 performance. Pre-tax income for the quarter more than doubled YoY to $0.8 million, with first-half pre-tax income of $1.5 million representing 1.7 times all of FY2024. Adjusted EBITDA also surged, rising 134% YoY in Q2 to $1.6 million, with a first-half figure of $2.8 million, which already exceeds 2024’s annual total.

Health In Tech (HIT), Synergy Corp. (NASDAQ: SNYR), and Power Metallic Mines Inc. (TSXV: PNPN | OTCQB: PNPNF) are trading in breakout zones, attracting strong interest from momentum traders and retail investors. Meanwhile, emerging names like Datavault AI Inc. (NASDAQ: DVLT), Bitfarms Ltd. (NASDAQ: BITF), Iovance Biotherapeutics Inc. (NASDAQ: IOVA), and HIVE Blockchain Technologies Ltd. (NASDAQ: HIVE) are gaining traction as stocks to watch amid growing demand for digital currency services, automation, and biotech innovation.

Health In Tech (NASDAQ: HIT)’s operational momentum continues to build. Health In Tech reported 24,839 billed enrolled employees, a YoY gain of 5,738, while expanding its distribution partnerships to 778 brokers, third-party administrators, and agencies — up 87% YoY. As of June 30, 2025, the company held a cash balance of $8.1 million, with net accounts receivable reduced to $1.3 million, reflecting disciplined execution and growing financial strength.

With financials accelerating, partnerships expanding, and sector tailwinds at its back, Health In Tech (NASDAQ: HIT) is cementing its status as a major player in next-gen insurance infrastructure.

 

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content."TSR" is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. "TSR" authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. "TSR" has not been compensated to produce content related to "Any Companies" appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email: Send Email
Country: United States
Website: http://www.thestreetreports.com

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.